Cargando…
A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis
Most clinical studies of Cannabis today focus on the contents of two phytocannabinoids: (-)-Δ(9)-trans-tetrahydrocannabinol (Δ(9)-THC) and cannabidiol (CBD), regardless of the fact that the plant contains over 100 additional phytocannabinoids whose therapeutic effects and interplay have not yet been...
Autores principales: | Berman, Paula, Futoran, Kate, Lewitus, Gil M., Mukha, Dzmitry, Benami, Maya, Shlomi, Tomer, Meiri, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155167/ https://www.ncbi.nlm.nih.gov/pubmed/30250104 http://dx.doi.org/10.1038/s41598-018-32651-4 |
Ejemplares similares
-
Full-Spectrum Cannabis Extract Microdepots
Support Controlled Release of Multiple Phytocannabinoids for Extended
Therapeutic Effect
por: Uziel, Almog, et al.
Publicado: (2020) -
The heterogeneity and complexity of Cannabis extracts as antitumor agents
por: Baram, Liran, et al.
Publicado: (2019) -
Fertilization Following Pollination Predominantly Decreases Phytocannabinoids Accumulation and Alters the Accumulation of Terpenoids in Cannabis Inflorescences
por: Lipson Feder, Carni, et al.
Publicado: (2021) -
Sex differences in medical cannabis-related adverse effects
por: Aviram, Joshua, et al.
Publicado: (2022) -
Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study
por: Aviram, Joshua, et al.
Publicado: (2020)